Dr. Devansu Tewari, MD
- Part D claims, 2024
- 216
- Publications
- 18
- Clinical trials
- 5
- Hospital affiliations
- 1
- Industry payments
- $3,821
- Practice address
- 27300 Iris Avenue, Moreno Valley, CA 92555
- Practice phone
- Call (951) 251-6530
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Tewari's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Devansu Tewari is a gynecologic oncologist in Moreno Valley, California
Dr. Tewari practices at Moreno Valley Medical Center in Moreno Valley, California, part of Kaiser Permanente.
Dr. Tewari's NPI, 1902827835, was assigned on July 23, 2006. Dr. Tewari graduated from UC Irvine School of Medicine in 1997. Dr. Tewari holds California license A068445.
- NPI
- 1902827835NPI Registry (opens in a new tab)
- NPI enumeration date
- July 23, 2006
- NPI status
- Active
- Practice phone
- (951) 251-6530
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 55
- Medical school graduation
- 1997
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Devansu Tewari practices at Moreno Valley Medical Center in Moreno Valley, California
Dr. Tewari's primary practice is Moreno Valley Medical Center, at 27300 Iris Avenue, Moreno Valley, CA 92555 in Riverside County. The practice phone is (951) 251-6530.
- Moreno Valley Medical Center27300 Iris Avenue, Moreno Valley, CA 92555 · Riverside CountyPhone(951) 251-6530
Source: Dmand AI Affiliation Data
Dr. Devansu Tewari is affiliated with 2 sites of care and 1 medical group
Dr. Tewari's primary practice is Moreno Valley Medical Center in Moreno Valley, California, part of Kaiser Permanente. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Tewari to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Devansu Tewari's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tewari practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Moreno Valley Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kaiser Permanente and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Devansu Tewari is one of 178 gynecologic oncologists in California
Gynecologic oncology is Dr. Tewari's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Tewari is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Tewari's licenses on file in 4 states: California, Oregon, Georgia and Hawaii.
Specialties and state licenses
- Gynecologic oncology, CaliforniaPrimary
- Oregon license
- Georgia license
- Hawaii license
Gynecologic oncologists near Dr. Tewari
Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Devansu Tewari's patients have a median age of 63
Across all payers, Dmand AI patient panel data puts Dr. Tewari's median patient age at 63, with 99% women.
Dr. Tewari's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 63
Patient panel by sex, all payers
- Women99%
- Men0%
Source: Dmand AI Patient Panel Data
Dr. Devansu Tewari wrote 216 Medicare Part D claims in 2024
In 2024, Dr. Tewari wrote 216 Medicare Part D claims for 71 patients. 85% of them were for generic drugs. CMS names the drug for 145 of them, across 8 drugs with 11 or more claims each, at $252,676 in total drug cost. In 2023, CMS named 116 claims across 7 drugs.
Dr. Tewari's Part D claims by kind of drug, 2024
- Generic184 claims85%
- Brand-name32 claims15%
Dr. Tewari's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1162024: 14525%
Drugs named by CMS: 8 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Devansu Tewari has 18 publications on record
Dmand AI links 18 papers to Dr. Tewari, published from 2006 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Papillomaviridae, Papillomavirus Infections and Uterine Cervical Neoplasms. Dr. Tewari has published most often in Gynecol Oncol. Dr. Tewari's most frequent co-authors are Bradley J. Monk, MD, Robert A. Burger, MD and Ronald D. Alvarez, MD.
Dr. Tewari's papers by year, 2006 to 2025
Topics Dr. Tewari writes about most
- Papillomaviridae
- Papillomavirus Infections
- Uterine Cervical Neoplasms
- Ovarian Neoplasms
- Cesarean Section
- Early Detection of Cancer
- Fallopian Tube Neoplasms
- Human Papillomavirus Viruses
Dr. Tewari's most frequent co-authors
- Bradley J. Monk, MD5 shared papers
- Robert A. Burger, MD4 shared papers
- Ronald D. Alvarez, MD1 shared paper
Recent publications by Dr. Tewari
J Womens Health (Larchmt)
Int J Gynecol Cancer
See who Dr. Tewari researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Tewari works with, so you can find a warm path to the right gynecologic oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Devansu Tewari has worked on 5 clinical trials
Dmand AI links Dr. Tewari to 5 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Uterine Cervical Neoplasms, Uterine Cervical Diseases and Carcinoma, Endometrioid. Gradalis, Inc. sponsors the most, 2.
Conditions in Dr. Tewari's trials
- Uterine Cervical Neoplasms
- Uterine Cervical Diseases
- Carcinoma, Endometrioid
- Fallopian Tube Diseases
- Patient Acceptance of Health Care
Investigators on the most trials with Dr. Tewari
- Jeffrey Wayne Elder, MD2 shared trials
- Stephanie Louise Gaillard, MD, PhD2 shared trials
- Adnan R. Munkarah, MD2 shared trials
Recent clinical trials with Dr. Tewari
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Vigil Engineered Autologous Tumor Cell Immunotherapy in Subjects With Stage IIIb-IV Ovarian Cancer in Clinical Complete Response Following Surgery and Primary Chemotherapy (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Devansu Tewari received $3,821 in industry payments from 2018 to 2025
CMS Open Payments shows 16 general payments to Dr. Tewari from 10 drug and device companies from 2018 to 2025. Honoraria make up the largest share, 65% of the total. Menarini Silicon Biosystems, Inc. paid the most, $2,600.
General payments to Dr. Tewari by program year, 2018 to 2025
General payments to Dr. Tewari by kind, 2018 to 2025
- Honoraria$2,50065%
- Food and beverage$1,32135%
Companies that paid Dr. Tewari the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Devansu Tewari has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Tewari, most recently CMS Stage 1 2012 in 2011.
Awards and honors for Dr. Tewari
- 2011
- CMS Stage 1 2012
- Undated
- ACOG Fellow
Source: Dmand AI Professional Profile Data
Dr. Devansu Tewari graduated from UC Irvine School of Medicine
Dr. Tewari graduated from UC Irvine School of Medicine in 1997. Dr. Tewari is a member of American College of Obstetricians and Gynecologists.
- Medical school
- Board certified in gynecologic oncology
- Board certified in obstetrics & gynecology
Source: Dmand AI Professional Profile Data
Dr. Devansu Tewari accepts plans from 2 insurance carriers
Dr. Tewari is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
- Kaiser Permanente
- CMS Medicare
Plan types Dr. Tewari accepts, by number of carriers
- EPO1
- HMO1
- Medicare1
- POS1
Source: Dmand AI Insurance Network Data
Sources for Dr. Devansu Tewari's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Devansu Tewari
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Devansu Tewari's NPI number?
Dr. Devansu Tewari's NPI number is 1902827835. It was assigned on July 23, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Devansu Tewari?
Dr. Devansu Tewari is a gynecologic oncologist in Moreno Valley, California. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).
Where does Dr. Devansu Tewari practice?
Dr. Tewari practices at 27300 Iris Avenue, Moreno Valley, CA 92555. Dr. Tewari's primary practice is Moreno Valley Medical Center in Moreno Valley, California, part of Kaiser Permanente. Dmand AI also links Dr. Tewari to 1 group practice or clinic.
What is Dr. Devansu Tewari's office phone number?
The practice phone on file for Dr. Tewari is (951) 251-6530.
What is Dr. Devansu Tewari's medical license number?
Dr. Tewari holds California license A068445, one of the licenses on file in 4 states.
Which states has Dr. Devansu Tewari been licensed in?
Dmand AI has state licenses on file for Dr. Tewari in California (1999 to 2027), Oregon (since 2006), Georgia (2024 to 2026) and Hawaii (2012 to 2026).
Which hospitals is Dr. Devansu Tewari affiliated with?
Dr. Tewari practices at Moreno Valley Medical Center in Moreno Valley, California.
What medical group is Dr. Devansu Tewari part of?
Dr. Tewari is linked to Southern California Permanente Medical Group.
Is Dr. Devansu Tewari board certified?
Yes. Dr. Tewari is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology.
Where did Dr. Devansu Tewari go to medical school?
Dr. Tewari graduated from UC Irvine School of Medicine in 1997.
Show 6 more questionsShow fewer questions
What drugs does Dr. Devansu Tewari prescribe most?
In 2024 Medicare Part D data, Dr. Tewari's most prescribed drugs by claims were Ibuprofen, Tamoxifen Citrate and Megestrol Acetate.
Has Dr. Devansu Tewari received payments from drug or device companies?
CMS Open Payments shows $3,821 in general payments to Dr. Tewari from 10 companies from 2018 to 2025. The largest total came from Menarini Silicon Biosystems, Inc.
How long has Dr. Devansu Tewari been practicing?
Dr. Tewari graduated from medical school in 1997, 29 years ago.
Does Dr. Devansu Tewari do research?
Dmand AI links 18 publications to Dr. Tewari, published from 2006 to 2025. Dr. Tewari has worked on 5 clinical trials.
Who does Dr. Devansu Tewari publish with?
Dr. Tewari's most frequent co-authors are Bradley J. Monk, MD (5 shared papers), Robert A. Burger, MD (4 shared papers) and Ronald D. Alvarez, MD (1 shared paper).
What insurance does Dr. Devansu Tewari accept?
Dr. Tewari is in network with 2 carriers, including Kaiser Permanente and CMS Medicare. EPO plans come from the most carriers, 1. Check the plan with the practice before a visit.
Selling to gynecologic oncology practices?
See gynecologic oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card